the aid library

Filter

403

CONSENSUS DOCUMENT FOR MANAGEMENT OF ESOPHAGEAL CANCER

Indian Council of Medical Research (ICMR) (2017) C1

Prepared as an outcome of ICMR Subcommittee on Esophageal Cancer | This consensus document on management of esophageal cancers summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular markers and research questions. It a ... more

The Spiritual Care Team: Enabling the Practice of Whole Person Medicine

Koenig, H.G. Duke UniversityMedical Center, Durham (2014) C2

We will soon be piloting a project titled “Integrating Spirituality into Patient Care” that will form “spiritual care teams” to assess and address patients’ spiritual needs in physician outpatient practices within Adventist Health System, the largest Protestant healthcare system ... more

Manejo clínico del COVID-19: unidades de cuidados intensivos - Documento técnico

Centro de Coordinación de Alertas y Emergencias Sanitarias Ministerio de sanidad - España (2020) C1

El presente documento técnico tiene la finalidad de guiar el manejode cuidados intensivosde los pacientes conCOVID-19 con undoble objetivo: lograr el mejor tratamiento del paciente que contribuya a subuena evolución clínica; ygarantizar los niveles adecuados de prevención y control de la ... more

Government policy interventions to reduce human antimicrobial use: A systematic review and evidence map

Van Katwyk, S. R.; Grimshaw, J. M.; et al (2019) C2

BACKGROUND: Growing political attention to antimicrobial resistance (AMR) offers a rare opportunity for achieving meaningful action. Many governments have developed national AMR action plans, but most have not yet implemented policy interventions to reduce antimicrobial overuse. A systematic evidenc ... e map can support governments in making evidence-informed decisions about implementing programs to reduce AMR, by identifying, describing, and assessing the full range of evaluated government policy options to reduce antimicrobial use in humans. METHODS AND FINDINGS: Seven databases were searched from inception to January 28, 2019, (MEDLINE, CINAHL, EMBASE, PAIS Index, Cochrane Central Register of Controlled Trials, Web of Science, and PubMed). We identified studies that (1) clearly described a government policy intervention aimed at reducing human antimicrobial use, and (2) applied a quantitative design to measure the impact. We found 69 unique evaluations of government policy interventions carried out across 4 of the 6 WHO regions. These evaluations included randomized controlled trials (n = 4), non-randomized controlled trials (n = 3), controlled before-and-after designs (n = 7), interrupted time series designs (n = 25), uncontrolled before-and-after designs (n = 18), descriptive designs (n = 10), and cohort designs (n = 2). From these we identified 17 unique policy options for governments to reduce the human use of antimicrobials. Many studies evaluated public awareness campaigns (n = 17) and antimicrobial guidelines (n = 13); however, others offered different policy options such as professional regulation, restricted reimbursement, pay for performance, and prescription requirements. Identifying these policies can inform the development of future policies and evaluations in different contexts and health systems. Limitations of our study include the possible omission of unpublished initiatives, and that policies not evaluated with respect to antimicrobial use have not been captured in this review. CONCLUSIONS: To our knowledge this is the first study to provide policy makers with synthesized evidence on specific government policy interventions addressing AMR. In the future, governments should ensure that AMR policy interventions are evaluated using rigorous study designs and that study results are published. more

The role of community health workers in COVID-19 vaccination: Implementation support guide

World Health Organization WHO (2021) C_WHO

This guide is intended to support national governments developing their national deployment and vaccination plans (NDVPs) for COVID-19 vaccines by outlining the roles, needs and opportunities for community health workers (CHWs) to contribute. This note builds on and is structured to align with the G ... more

Genomic sequencing of SARS-CoV-2: a guide to implementation for maximum impact on public health

World Health Organization WHO (2021) C_WHO

8 January 2021 Sequencing enabled the world to rapidly identify SARS-CoV-2 and develop diagnostic tests and other tools for outbreak management. Continued genome sequencing supports the monitoring of the disease’s spread and evolution of the virus. Accelerated integration of genome sequencing int ... more

Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis
recommended

Chu, D.K.; E.A Akl, S. Duda, et al. (2020) CC

a systematic review and meta-analysis Derek K Chu et al. on behalf of the COVID-19 Systematic Urgent Review Group Effort (SURGE) study authors. Published: The Lancet June 01, 2020 DOI: https://doi.org/10.1016S0140-6736(20)31142-9 'We did a systematic review of 172 observational studies in health- ... more

Pruebas diagnósticas para el SARS-CoV-2: orientaciones provisionales, 11 de septiembre de 2020

World Health Organization WHO (2020) C_WHO

Available in Arabic, Chinese, English, French, Portuguese, Russian and Spanish https://apps.who.int/iris/handle/10665/334254

WHO consolidated guidelines on tuberculosis: module 4: treatment: drug-resistant tuberculosis treatment,update

World Health Organization WHO (2022) C_WHO

These guidelines group all recommendations on TB care and support in one document and are complemented by an operational handbook. The guidelines are to be used primarily by national TB programmes, or their equivalents in Ministries of Health, stakeholders and technical organizations working on ... more

Epidemiology of Peripheral Artery Disease and Polyvascular Disease

Aday A.W.; Matsushita, K. Circulation Research (2021) CC

Atherosclerotic lower-extremity peripheral artery disease (PAD) is increasingly recognized as an important cause of cardiovascular morbidity and mortality that affects more than 230 million people worldwide. Traditional cardiovascular risk factors, including advanced age, smoking, and diabetes, are ... more

Hypertension et COVID-19

World Health Organization WHO (2021) C_WHO

Note d’information scientifique, 17 juin 2021

Всемирный доклад о наркотиках 2008

Анджела Ми, Тибо ле Пишон, Коэн Буссинк e tal. Организация Объединенных Наций, UNODC (2009)

Во Всемирном докладе о наркотиках содержится комплексная информация по положению в области незаконных наркотиков. В нем представлены подробные оценки и тенденци� ... more

COVID-19: Guidelines for case-finding, diagnosis, management and public health response in South Africa
recommended

Bham A., J. Bhiman, F. Bongweni et al. Centre for Respiratory Diseases and Meningitis and Outbreak Response (2020) C2

The information contained in this document, be it guidelines, recommendations, diagnostic algorithms or treatment regimens, are offered in this document in the public interest. To the best of the knowledge of the guideline writing team, the information contained in these guidelines is correct. Imple ... more

Rehabilitation considerations during the COVID-19 outbreak

Pan American Health Organization PAHO, World Health Organization WHO (2020) C_WHO

Severe cases of COVID-19 are associated with rehabilitation needs related to the consequences of ventilatory support, and prolonged immobilization and bed rest. These may include: − Impaired lung function; − Physical deconditioning and muscle weakness; − Delirium and other cognitive impairment ... more

El Informe de la Nutrición Mundial 2017. Alimentar los ODS

Informe de la Nutrición Mundial (2017) C1

EPI 5: Anti-epileptic medicines for medication resistant convulsive epilepsy. [New 2015]

mhGAP; WHO (2015) C_WHO

SCOPING QUESTION: For adults and children with medication-resistant convulsive epilepsy, which anti-epileptic medications produce benefits and/or harm in the specified outcomes when compared to a placebo or a comparator?

COVID Reference 2021.6 ES

Kamps, B.S.; C. Hoffmann, A. Gualani Gualani; and J. Garcia-Rosales Delgado (2021) CC

6a edición clínica. Nuevo: 4. Vacunas (26 de abril); Nuevo: 5. Pruebas y procedimientos de diagnóstico (7 de abril); Nuevo: 7. COVID-19 persistente (7 de abril)

Atendimento domiciliar para pacientes com COVID-19 que apresentam sintomas leves e manejo de seus contatos

Pan American Health Organization (PAHO), OPS (2020) C_WHO

Orientação provisória 17 de março de 2020 Esta orientação rápida destina-se a profissionais de saúde pública e de prevenção e controle de infecção (PCI), gestores e profissionais de saúde, ao abordar questões relacionadas ao atendimento domiciliar de pacientes com suspeita de infecç ... more

Retention and mortality outcomes from a community-supported public–private HIV treatment programme in Myanmar

Mburu, Gitau; Aung Zayar Paing; Nwe Ni Myint et al. (2016) CC

Journal of the International AIDS Society 2016, 19:20926
There is a growing interest in the potential contribution the private sector can make towards increasing access to antiretroviral therapy (ART) in low‐ and middle‐income settings. This article describes a public–private partnership ... more

Overlapping Vulerabilities - The impacts of climate change on humanitarian needs

Norwegian Red Cross (2019) C1